Cura Partners Lied About THC Content In Vapes, Suit Says
Law360 (July 27, 2020, 6:30 PM EDT) -- A unit of pot giant Curaleaf's vaping subsidiary Cura Partners has been hit with a proposed class action in Oregon state court alleging its vape pens contain significantly less THC than advertised, with the plaintiff seeking more than $10 million in damages.
The suit against Cura, which settled a mislabeling investigation by Oregon regulators earlier this year, argues that the company's Select Elite brand vape pens contain only about 55% THC, less than three-quarters of the 80-95% advertised on the packaging for the company's premium products.
"The THC claims are false and misleading," plaintiff Brian Blackford said. "Independent lab testing reveals...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!